Does your model know its limits? Leveraging uncertainties to find better compounds
If you’re using predictive models in your molecule design and optimisation, an accurate uncertainty estimate can be just as important…
Watch industry leaders from Novartis, Apollo Therapeutics and Eikon Therapeutics as they discuss their highs and lows, experience and advice, on running a successful drug discovery team.
Our speakers include Hilary Beck, VP, Head of Chemistry at Eikon Therapeutics, Dean Phillips, Director at Novartis, and Susanne Wright, Director, Chemistry Research and Operations at Apollo Therapeutics.
If you’re interested in the skills needed across successful teams, strategies for communication, collaboration and leadership, or hearing personal anecdotes from leading figures in the field, catch-up the discussion of this insightful panel.
More webinars
How to perform fast and accurate 3D ligand-based affinity predictions
Binding affinity prediction continues to be a challenge in computer-aided drug design, especially in the absence of a high-quality target…
Computational and experimental integration in modern cancer drug discovery: The synthetic lethality approach
Join us for a webinar featuring experts from IDEAYA Biosciences and CDD Vault as they explore how synthetic lethality is…
